AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
+4.09%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$306M
AUM Growth
+$306M
Cap. Flow
+$17M
Cap. Flow %
5.56%
Top 10 Hldgs %
50.4%
Holding
90
New
22
Increased
26
Reduced
13
Closed
13

Top Buys

1
APGE icon
Apogee Therapeutics
APGE
$22.3M
2
CRNX icon
Crinetics Pharmaceuticals
CRNX
$13.4M
3
XENE icon
Xenon Pharmaceuticals
XENE
$8.2M
4
KRYS icon
Krystal Biotech
KRYS
$6.67M
5
ACLX icon
Arcellx
ACLX
$6.23M

Top Sells

1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$12.3M
2
BIIB icon
Biogen
BIIB
$11.4M
3
VTYX icon
Ventyx Biosciences
VTYX
$3.3M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.97M
5
FGEN icon
FibroGen
FGEN
$2.65M

Sector Composition

1 Healthcare 94.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SWTX
51
DELISTED
SpringWorks Therapeutics
SWTX
$961K 0.27%
41,581
-88,419
-68% -$2.04M
MIRM icon
52
Mirum Pharmaceuticals
MIRM
$3.75B
$948K 0.27%
30,000
– –
TVTX icon
53
Travere Therapeutics
TVTX
$1.75B
$894K 0.25%
+100,000
New +$894K
PODD icon
54
Insulet
PODD
$24.2B
$797K 0.22%
+5,000
New +$797K
BBIO icon
55
BridgeBio Pharma
BBIO
$9.91B
$791K 0.22%
30,000
-5,133
-15% -$135K
BHVN icon
56
Biohaven
BHVN
$1.71B
$784K 0.22%
+30,156
New +$784K
TECX
57
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$770K 0.22%
+500,000
New +$770K
IMTXW
58
DELISTED
Immatics N.V. Warrants
IMTXW
$663K 0.19%
187,204
– –
PBYI icon
59
Puma Biotechnology
PBYI
$258M
$532K 0.15%
202,349
– –
PMN icon
60
ProMIS Neurosciences
PMN
$23.7M
$527K 0.15%
+265,958
New +$527K
CNTX icon
61
Context Therapeutics
CNTX
$75.6M
$497K 0.14%
328,817
+61,243
+23% +$92.5K
NUVB icon
62
Nuvation Bio
NUVB
$1.08B
$335K 0.09%
250,000
– –
BCAB icon
63
BioAtla
BCAB
$28.7M
$306K 0.09%
180,000
-145,000
-45% -$247K
ALDX icon
64
Aldeyra Therapeutics
ALDX
$350M
$296K 0.08%
44,348
-105,652
-70% -$706K
NAMSW icon
65
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$64M
$260K 0.07%
137,000
+100,000
+270% +$190K
NLSP icon
66
NLS Pharmaceutics
NLSP
$9.96M
$140K 0.04%
200,455
-199,545
-50% -$140K
ARAV
67
DELISTED
Aravive, Inc. Common Stock
ARAV
$45.7K 0.01%
+346,511
New +$45.7K
RCKTW icon
68
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.17M
$7.5K ﹤0.01%
75,000
– –
ACRS icon
69
Aclaris Therapeutics
ACRS
$223M
– –
0
– –
ARKG icon
70
ARK Genomic Revolution ETF
ARKG
$1.05B
– –
0
– –
AXSM icon
71
Axsome Therapeutics
AXSM
$6.09B
– –
-12,500
Closed -$898K
BIIB icon
72
Biogen
BIIB
$20.8B
– –
-40,000
Closed -$11.4M
CABA icon
73
Cabaletta Bio
CABA
$144M
– –
-125,000
Closed -$1.61M
ETNB icon
74
89bio
ETNB
$1.37B
– –
0
– –
EYPT icon
75
EyePoint Pharmaceuticals
EYPT
$827M
– –
0
– –
1 2
3
4